Classified information.
Authorized users only.
Caduceus official document.
Do not replicate.
File 0231-09. Access:// |
REDACTED = [REDACTED] CLASSIFIED INFORMATION.
FILE 0231-09
DOCTOR, MIRA "NAOMI" KIMISHIMA
君島直美、博士
(なおみ・ミラ・きみしま)
DIRECTORY ://
CHOOSE SOURCE: |
CADUCEUS U.S.A.
REGISTRATION IDENTIFICATION NUMBER
[720861]
STATUS: UNRESTRICTED USER ACCESS in
[GENERAL SURGERY], [PATHOLOGY], [RADIOLOGY], [INTENSIVE CARE], [EMERGENCY DEPARTMENT], [PHARMACOLOGY RESEARCH LABORATORY]
CADUCEUS JAPAN
REGISTRATION IDENTIFICATION NUMBER
[509931]
STATUS: COMPLETE RESTRICTED USER ACCESS in
[ALL DEPARTMENTS]
CADUCEUS EUROPE
REGISTRATION IDENTIFICATION NUMBER
[408362]
STATUS:
MONITORED-RESTRICTED USER ACCESS in
[GENERAL SURGERY], [PATHOLOGY], [EMERGENCY DEPARTMENT]
CUMBERLAND INSTITUTE OF FORENSIC MEDICINE
REGISTRATION IDENTIFICATION NUMBER
[070288]
STATUS:
UNRESTRICTED USER ACCESS in
[ALL DEPARTMENTS]
RESURGAM FIRST CARE MEDICAL CENTER
REGISTRATION IDENTIFICATION NUMBER
[430870]
STATUS: UNRESTRICTED USER ACCESS in
[ALL DEPARTMENTS]
OFFICIAL AFFILIATIONS:
FEDERAL BUREAU OF INVESTIGATIONS, U.S.A.
STATUS: [REDACTED]
DELPHI CORPORATIONS
STATUS: [REDACTED]
EIDOTH PHARMACEUTICALS STATUS: [REDACTED]
ACROPOLIS PHARMACEUTICALS
STATUS: [REDACTED]
USAMRIID (UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE for INFECTIOUS DISEASES)
STATUS: [REDACTED]
ELYSIUM MEDICAL CENTER
STATUS: [REDACTED]
OFFICIAL CREDENTIALS:
[REDACTED] Daigaku, JAPAN:
Bachelor of Science (B.S.)
[REDACTED] Ika-Daigaku, JAPAN:
Doctor of Medicine (M.D.)
[REDACTED] Research University, U.S.A.:
Master of Biomedical Science (M.B.S.)
CURRENT [ACTIVE] LICENSURE:
Physician
Medical License
Physician
Surgical License
Medical Examiner
Forensic Examiner License
NAME: Mira Kimishima, B.S., M.D., M.B.S.
( A.K.A. "Nozomi Weaver"
A.K.A. "Naomi Kimishima"
A.K.A. [REDACTED] )
D.O.B.: [REDACTED]
ORIGIN: Okinawa, Japan
AGE: 36 years
HEIGHT: 5'6" (168cm)
WEIGHT: 115lbs (52kg)
HAIR: silver
EYES: blue
RELEVANT CHRONOLOGICAL HISTORY
I. REGARDING THE OKINAWA INCIDENT
Following the unprompted and inappropriate use of the unknown [REDACTED] during heart transplant surgery on [REDACTED] on the date of [REDACTED], in Okinawa, JAPAN, Dr. Kimishima was forcibly removed from the operating suite by hospital security. The following day, Dr. Kimishima was brought before the [REDACTED] University Hospital Board, which issued an immediate federal investigation into her actions. Within one week, on the date of [REDACTED], Dr. Kimishima was charged with [REDACTED] on a federal level, and subsequently, promptly disbarred of medical practice, stripped of her medical licensure. Further investigation into the use of [REDACTED] in this incident led to an active arrest of Dr. Kimishima thereafter. Dr. Kimishima faced the [REDACTED] Federal Investigations Department in trial, and was advised to [REDACTED] as soon as possible. As a result, on the date of [REDACTED], Dr. Kimishima emigrated from Japan to [REDACTED], seeking refugee status.
——
——
II. REGARDING THE DELPHI TERRORIST THREAT
Once in [REDACTED], following her disbarment in Okinawa, JAPAN, Dr. Kimishima was recruited to DELPHI CORPORATIONS on [REDACTED]. Dr. Kimishima was assigned partnership to OFFICER NAVEL. Her duties within DELPHI included: surgery, live human experimentation, and research. Dr. Kimishima, in partner with DELPHI CORPORATION, knowingly treated and performed research, exploratory surgery, and treatments to prolong the lives of, live humans infected with GANGLIATED UTROPHIN IMMUNO LATENCY TOXIN (GUILT). Dr. Kimishima has claimed that her command was under the strict order of Dr. [REDACTED] and his father, [REDACTED]. Dr. Kimishima has formally claimed no regret or responsibility for assisting with the DELPHI CORPORATION biological warfare creation and development of GUILT.
——
——
III. REGARDING DELPHI'S LAST STAND
On [REDACTED], government officials raided the base and stronghold of DELPHI CORPORATIONS, within which Dr. Kimishima was located. The sudden lethal outbreak of GUILT was attempted to be countered by CADUCEUS U.S.A., and led officials to seize DELPHI CORPORATION as the sole cause. Dr. Kimishima fled the organization with OFFICER NAVEL at this time. Upon subsequent arrest upon being located by officials, Dr. Kimishima, on the date of [REDACTED], formally pleaded for federal immunity and dismissal of all charges against her, in return for offering her skills to help cure the GUILT outbreak. As a result of the leading GUILT-treating surgeon at the time, DR. DEREK STILES, contracting the disease shortly thereafter, Dr. Kimishima was to be granted immunity in exchange for treating him with a possible cure serum she had helped to produce.
——
——
IV. REGARDING TREATMENT AND CURE OF GUILT
Directly after the raid of DELPHI CORPORATION and arrest of Dr. Kimishima, she willingly turned her back to DELPHI CORPORATIONS, and performed surgery through CADUCEUS U.S.A. facilities. It was discovered that Dr. Kimishima had helped to research a strain of GUILT, under the wing of Dr. [REDACTED], to be used as a cure for the toxin. In her fleeing from DELPHI CORPORATION, Dr. Kimishima had stolen away with this mutated strain of GUILT. Using it to create a treatment for GUILT, on the date of [REDACTED], Dr. Kimishima performed a successful surgery on DR. DEREK STILES, freeing him of three strains of GUILT: IMMATURE KYRIAKI, MATURE KYRIAKI, and PARASKEVI. On this same date, Dr. Kimishima then handed over the concocted cure to CADUCEUS U.S.A. officials, and was granted immunity, and a dismissal of all her previous criminal charges as promised. Instated in CADUCEUS U.S.A., Dr. Kimishima then helped to cure many people affected by the outbreak of GUILT.
——
——
V. REGARDING THE AFTER-EFFECT OF GUILT
On the date of [REDACTED], Dr. Kimishima was formally diagnosed with "GUILT SYNDROME," after collapsing mid-surgery, during a routine operation on the patient of [REDACTED]. She openly expressed concerns of her inability to perform surgery anymore, from there forth.
——
——
VI. REGARDING THE CUMBERLAND INSTITUTE
After the wave of GUILT outbreaks was stabilized, Dr. Kimishima took time away from work to travel and recuperate. After, from the date of [REDACTED] onwards, Dr. Kimishima was employed in the department of FORENSICS and PATHOLOGY at the CUMBERLAND INSTITUTE OF FORENSIC MEDICINE (CIFM) In partnership with RESURGAM FIRST CARE MEDICAL CENTER, and the UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE for INFECTIOUS DISEASES (USAMRIID), Dr. Kimishima began work as a forensic pathologist for the first time since the DELPHI CORPORATION incidents. She was assigned F.B.I. AGENT 'LITTLE GUY' as a partner in her forensic investigations.
——
——
VII. REGARDING THE ROSALIA VIRUS
From the date of [REDACTED], following the incident of DR. ALBERT SARTRE at CUMBERLAND COLLEGE, Dr. Kimishima resolved to help solve the case of a new, evolving virus, termed as ROSALIA. During the spread of the ROSALIA VIRUS, Dr. Kimishima assisted to research a cure and treatment, along with the following colleagues: DR. DEREK STILES, DR. TOMOE TACHIBANA, DR. HANK FREEBIRD, MARIA TORRES, DR. GABRIEL CUNNINGHAM, and DR. ERHARD MULLER.
——
——
VIII. REGARDING THE ROSALIA INFECTION
On the date of [REDACTED], directly after the ROSALIA VIRUS prevalence had begun to diminish due to a new treatment and cure, Dr. Kimishima collapsed, and was found to also be infected with the ROSALIA VIRUS.
RELEVANT CHRONOLOGICAL MEDICAL HISTORY
I. "On [REDACTED] at 11:30AM, Dr. Naomi Kimishima, a previously healthy [REDACTED]-year-old female, complained of shortness of breath just seconds before collapsing. Patient was engaged at the time of the incident as the primary surgeon at [REDACTED] Hospital, engaged in an operation. At the scene, pt was unresponsive, pale, and in cardiorespiratory arrest; HR 0, BP 80/20, RR 0. Immediately CPR was performed for 10 mins by staff in the OR. A defibrillator was applied to the pt, twice in the span of another 10 mins with intermittent chest compressions. After 25 consecutive mins of cardiorespiratory resuscitation, pt was revived with HR 30, BP 80/30, RR 7. Pt remains unconscious. Assumed v-fib for cause of cardiac arrest. Pt was placed on ventilator, 12-lead, and admitted immediately to ICU. Administered atrophine in IV drip. Upon following work-up, no external injuries were found. Complete bloodwork returned with abnormally low CBC leukocyte count, but otherwise unremarkable. MRI and CT normal on all counts. Blood and saliva smears were performed; chiral reaction positive but diminished. Possible GUILT infection. Symptoms and findings are unusual; cause of incident unknown. Current diagnosis: unknown." - SIGNED: [REDACTED], M.D.
——
——
II. "Dr. Naomi Kimishima presented today, 4:15 PM on [REDACTED], with reported hemoptysis, fever, and cold chills. Pt was non-compliant with suggested treatment and examination methods, and thus no physical exam was performed. Pt voiced concerns over her own health, asked for advice, but then became notably agitated and left when advised to allow a formal physical exam." - SIGNED: GABRIEL CUNNINGHAM, M.D.
——
——
III. CADUCEUS ADMINISTRATION OFFICIAL UPDATE: On [REDACTED], medical doctor Naomi Kimishima was diagnosed with an unknown illness, termed "GUILT SYNDROME." The effects of this syndrome, upon further research, seems to be the direct result of prolonged, continuous exposure to the GANGLIATED UTROPHIN IMMUNO LATENCY TOXIN (GUILT) virus. Naomi Kimishima was previously a researcher and surgeon at DELPHI CORPORATION, a position which can be linked as the direct cause of this new illness. Chiral reaction tests are continuously positive for GUILT, though she is symptomatic at least 60% of the time. The mechanism behind this unknown syndrome is one which, on a molecular level, has genetically inserted a mutated string of the following amino acids, into the outer mitochondrial membrane of cardiac cells: valine-tryptophan-arginine-arginine-proline-valine-leucine-lysine-arginine-isoleucine. The mutation, though still very much unknown and not well-understood at this point, spreads via gap junctional responses, and thus has undoubtedly begun to surface in all cardiac cells of the patient via a rapid transcription rate of cardio logically relevant proteins, and the rapid generation of shear force between cardiac cells during cardiac contraction. This may or may not because the cause for a ventricular fibrillation and subsequent cardiac arrest (as previously detailed in the incident report above). Current research is ongoing on this matter. As Naomi Kimishima continues to present with varying symptoms, more data is being gathered to determine the cause of this genetic mutation. - SIGNED: ADMIN NUMBER [REDACTED].
——
——
IV. CADUCEUS ADMINISTRATION OFFICIAL UPDATE: At this moment in time, 1:20PM on [REDACTED], Naomi Kimishima is currently undergoing emergency open-heart surgery. It was reported that she had contracted the ROSALIA VIRUS, and suffered an onslaught of various symptoms before going into cardiopulmonary arrest, and falling unconscious. Prognosis is currently unknown. DEREK STILES, M.D., and ERHARD MULLER, M.D., are currently the performing surgeons on her operation. - SIGNED: ADMIN NUMBER [REDACTED].
——
——
V. CADUCEUS ADMINISTRATION OFFICIAL UPDATE: At this moment in time, 5:00PM on [REDACTED], Naomi Kimishima is still unconscious and undergoing surgery in the care of DEREK STILES, M.D., and ERHARD MULLER, M.D. Word has been received from the surgical suite that Naomi Kimishima has been confirmed to be infected with the ROSALIA VIRUS, which has reacted negatively with her pre-existing genetic condition of "GUILT SYNDROME," and has caused a lethal mutation within her body. This new strain of SUPERINFECTION will appropriately be termed TWISTED ROSALIA, or ROSALIA'S GUILT. Treatment method and basis of this mutation is currently unknown. Operating physicians have been given an all-clear to save the patient by whatever means necessary, by the Chief of CADUCEUS U.S.A., SIDNEY KASAL, M.D. Additional support staff have been sent to the operating room, including: GABRIEL CUNNINGHAM, M.D., GREG KASAL, M.D., and ANGIE THOMPSON, RN. - SIGNED: ADMIN NUMBER [REDACTED].
——
——
VI. OFFICIAL SURGICAL REPORT: This operation was performed for the first time, with improvisation, and with an unclear knowledge of the illness being faced. This method of surgery was officially approved by SIDNEY KASAL, M.D., Chief of CADUCEUS U.S.A., and thus any possible negative results of the operation are waived from the records of all the performing surgeons and staff. The one goal is to only stabilize the patient, Naomi Kimishima. Location of operation is the heart. TWISTED ROSALIA has been visible collected as a colonizing infection in cardiac cells. After initial incision and appropriate retraction of sternum and ribs, the heart was visualized. Upon ultrasonic examination, each chamber of the heart was agreed to be opened. Four incisions were performed, one in each of the atria, one in each of the ventricles, on the superomedial surfaces of each chamber. Inside of each chamber were visualized colonies of hardened flesh, which were immediately resected with the use of a laser. When colonies had begun to visibly mutate, use of the laser would inevitably cause the entire she'll of each colony to regenerate. Timing was essential to remove even the outer shell of each viral colony in this manner. Using a gelator then to reduce the activity of each colony, it was found that the stabilizing effect only lasts for a few moments at a time. Stabilizer/gelator was only effective if injected into all of the colony and its visible extension at once, which thus allowed a window of time in which the main body of the infection could be excised and removed from the cardiac cells. The shattering of the colony shells did produce lacerations on the surrounding cardiac tissue, but these were appropriately repaired with sutures. Colonies still continued to mutate across the heart, until they were cauterizes and drained away as much as possible. The infection is one that clearly spreads very quickly, for the colony is left to regenerate if untouched even for a mere minute. Using an antiviral injection produced from the anti-GUILT serum, bruises and scars of cardiac tissue from the infection were treated. After all four colonies were removed and surrounding damage repaired as much as possible, the four incisions were sutured. During this time, the patient's vitals had dropped dangerously low, and thus before proceeding with the operation further, saline and infusion drips were adjusted, and another stabilizer was introduced to the patient's body. Vitals did not return to a normal level, but remained stable for at least five minutes without disruption, so the decision to continue the surgery was made. In the intra-atrial and intra-ventricular septa, one long, medial, superior-to-inferior incision was performed, sparing the surrounding vasculature as much as possible. A cardioplegic solution, a mixture based in calcium chloride, was decided upon to be used. Upon injecting the solution into the heart, it was determined there would be a time constraint of a maximum of three minutes before the patient would flatline, and go into complete cardiac arrest. With this in mind, the cardioplegic drug was administered, and immediately the patient's vital signs began to diminish. Heart rate dropping to null at a fast pace, as well as her breathing rate. As quickly as possible, the remaining un-shelled colonies were excised from the tissue within the septum, and a protective membrane surrounding it all was also removed in time. By the cap of three minutes exactly, the patient flatlined. A pulse was lost entirely, breathing had stopped. Patient was in full cardiac arrest, but after atropine and manual cardiac massage and fibrillation, a heartbeat was regained only less than a minute later. While the patient was stabilized, the incisions were sutured in the heart. Finally, an antiserum of both ROSALIA VIRUS and GUILT medications was injected into the cardiac tissue in multiple locations. The effect would temporarily suppress her immune system, but would insure that the mutated virus should not return. Though the patient might continue to suffer from symptoms of TWISTED ROSALIA elsewhere in the body, the chance of this happening is relatively low. Patient was stabilized, cleaned, and transferred to the ICU for post-surgical monitoring. Operation was deemed to be a success. - SIGNED: ADMIN NUMBER [REDACTED].
——
——
VII. "Post-op exam on Naomi Kimishima showed no abnormalities aside from what was expected. Low WBC count, lucidity, and generalized pain and nausea. Pt is currently on the following medications and regiments: [REDACTED], [REDACTED], [REDACTED]." SIGNED: GABRIEL CUNNINGHAM, M.D.
Biography originally published to Twishort
on 29 August, 2015.
Important information.
Please read thoroughly.
This character is a canon character from the Trauma Center/Trauma Team video game series. The account @atwistedrosalia is a fictional roleplay/writing and fan account, and has no official affiliation with Atlus, Nintendo, or any sponsors. Any pictures or art posted on this account are copyright of their respective owners, unless otherwise noted. Please do not duplicate tweets or excerpts posted on this account without direct written authorization. All original writing and media ©atwistedrosalia. RTs do not equal endorsement.
@atwistedrosalia is multiverse (MV), alternate universe (AU), multi-SL, and is also welcoming of all original character (OC) interactions. No RP in DMs, please and thank you. This account does not plot or plan “ships” with other characters, regardless of who the character is. Please do not ask for this. Relationships (romantic and sexual) will be formed through developing chemistry between characters, not simply for the sake of “shipping”, smut/sex, or romance.
Please be aware that this account contains R-rated and mature (R-18+) information and is NSFW (Not Safe For Work). The following may be present on this account at any given time without further explicit warning, so please read and interact with this account at your own risk.
TRIGGER WARNING FOR: blood/gore, extreme violence with/out mutilation and/or dismemberment, graphic descriptions of murder/physical torture, cannibalism, explicit sexual themes and situations, explicit language, illicit/prescription drug usage, alcohol, mental manipulation, hallucinations and nightmares, mental and physical illnesses (including, but not limited to, Asperger's/autism and encephalitis), graphic descriptions of medical procedures, religious/sacrilegious themes, etc.
This account will not write and/or entertain interaction with anything relating to the following: rape; underage sexual content (<18 years); A/B/O verse; “lewd”/overtly sex-focused accounts or threads; political statements; any form of racial/ethnic, gender/sexual/romantic intolerance, phobia, or hatred; God-modding; etc. This list is not exhaustive. Write and interact with good taste, a level head, and respect. If you are rude, you will immediately be COOKED AND SERVED FOR DINNER blocked and reported.
@atwistedrosalia does not automatically follow back. The decision to follow is done at the discretion of the writer, and takes into account the following: possibility of interaction between characters/accounts; quality of tweets; RTs or quote-RTS. An excessive use of emojis, inappropriate language/characterization, OOC tweets, or quote-retweets, will make the writer less likely to follow an RP account. Please do not ask outright to be followed back, or why you have not been followed back.
If you would like to write or plot with this account, please contact via @/mention or DM. Upon agreeing to write/plot/RP, it is assumed that you have read and understood all of the information above. Please ask questions if you are unsure of anything mentioned here. Thank you.